| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Janux Therapeutics, Inc. | Chief Medical Officer | Common Stock | 52,286 | $829,255 | $15.86 | 02 Jan 2026 | Direct |
| Janux Therapeutics, Inc. | Chief Medical Officer | Stock option (right to buy) | 101,500 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | 02 Jan 2026 | 3 | -$37,263 | 4 | Chief Medical Officer | 02 Jan 2026, 21:00 |
| JANX | Janux Therapeutics, Inc. | 02 Jan 2025 | 2 | $0 | 4 | Chief Medical Officer | 03 Jan 2025, 20:10 |
| JANX | Janux Therapeutics, Inc. | 01 Jan 2025 | 0 | $0 | 3 | Chief Medical Officer | 03 Jan 2025, 20:00 |